Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles Medical Countermeasures February 1, 2016 …
Pharma Leaders Issue Joint Declaration on Combating Antimicrobial Resistance Antimicrobial Resistance January 21, 2016 …
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Trial Medical Countermeasures January 20, 2016 …
NIAID Awards 5M for Non-Traditional Bacterial Infection Treatments Antimicrobial Resistance January 12, 2016 …